What are the major opportunities in the Nexviazyme market? What are the strategies for the Nexviazyme market?

For detailed insights on the major opportunities and strategies in the Nexviazyme market, Read More

How does the Nexviazyme market relate to the overall economy and other similar markets?

For detailed insights on Nexviazyme's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Nexviazyme market growth? SWOT analysis of the Nexviazyme market.

For detailed insights on the key dynamics influencing the Nexviazyme market growth and SWOT analysis of the Nexviazyme industry, Read More

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Nexviazyme Global Market Report 2025

Name: Nexviazyme Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Indication (Infantile-Onset Pompe Disease, Late-Onset Pompe Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Adult, Pediatric, Geriatric)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Nexviazyme Market?

Nexviazyme is a medication designed for the treatment of pompe disease, a rare genetic disorder that affects muscle and respiratory function. It is a biological therapy developed to address the underlying cause of the disease by replacing the missing or deficient enzyme, acid alpha-glucosidase (GAA), to help improve muscle strength and respiratory function in patients.

The main indication types of nexviazyme are infantile-onset pompe disease and late-onset pompe disease. Infantile-onset pompe disease is a rare genetic disorder that appears in infants, typically within the first few months of life. The distribution channels are hospital Pharmacies, Retail pharmacies, and online pharmacies, and they are used by various end users such as adults, pediatrics, and geriatrics.

Nexviazyme Market Size and growth rate 2025 to 2029: Graph

What Is The Nexviazyme Market Size 2025 And Growth Rate?

The nexviazyme market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rising prevalence of pompe disease globally, growing investments in the rare disease treatment sector, expanding patient access to innovative therapies due to improved healthcare infrastructure, FDA approval of nexviazyme for late-onset pompe disease, and positive clinical trial results demonstrating efficacy in improving respiratory function and mobility.

What Is The Nexviazyme Market Growth Forecast?

The nexviazyme market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing global demand for enzyme replacement therapies, growing government support for rare disease treatments, expansion of healthcare systems in emerging markets, rising research and development investments in gene therapies and related treatments, and rising healthcare spending in developed economies. Major trends in the forecast period include a shift towards more targeted and efficient enzyme therapies, growth in gene therapy research as complementary to enzyme therapies, increased use of digital health technologies for treatment monitoring, development of combination therapies for pompe disease, and advancements in biopharmaceutical manufacturing for better production efficiency.

Book your 30 minutes free consultation with our research experts

How Is The Nexviazyme Market Segmented?

The nexviazyme market covered in this report is segmented –

1) By Indication: Infantile-Onset Pompe Disease, Late-Onset Pompe Disease

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Adult, Pediatric, Geriatric

What Is Driving The Nexviazyme Market? Rising Prevalence Of Pompe Disease To Drive Growth In The Market

The increasing prevalence of pompe disease is expected to drive the nexviazyme market going forward. Pompe disease is a rare genetic disorder caused by a deficiency of the enzyme acid alpha-glucosidase, leading to the buildup of glycogen in muscles, which causes progressive muscle weakness and respiratory issues. The increasing prevalence of pompe disease can be attributed to advancements in diagnostic technologies, such as genetic screening and newborn screening programs. Nexviazyme is used as an enzyme replacement therapy to treat late-onset pompe disease by reducing glycogen buildup in muscles, improving respiratory function, and improving mobility. For instance, in December 2024, according to a report published by the International Brain Research Organization, a France-based federation of neuroscience organizations, the global birth prevalence of Pompe disease was noted to be 2.0 cases per 100,000 live births. Moreover, the prevalence of infantile-onset Pompe disease was 1.0 cases per 100,000 live births, while late-onset Pompe disease had a prevalence of 2.4 cases per 100,000 live births. Therefore, the increasing prevalence of Pompe disease drives the nexviazyme market.

Who Are The Major Players In The Global Nexviazyme Market?

Major companies operating in the nexviazyme market include Sanofi S.A.

What Are The Key Trends Of The Global Nexviazyme Market? Regulatory Approval Propels Nexviazyme As A Breakthrough Therapy For Late-Onset Pompe Disease

The key trend in the nexviazyme market is the development of new treatment options for patients aged one year and older with late-onset Pompe disease. Nexviazyme, an enzyme replacement therapy (ERT), is designed to target the mannose-6-phosphate (M6P) receptor, enhancing cellular enzyme uptake to treat late-onset Pompe disease, a progressive muscle disorder. For instance, the Food and Drug Administration (FDA), a US-based federal agency, approved Nexviazyme for patients aged one year and older with late-onset Pompe disease. Clinical trials demonstrated its ability to improve respiratory function and walking distance, establishing it as a transformative therapy in the treatment of rare diseases.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Nexviazyme Market? Sanofi Enters Exclusive License Agreement With Maze Therapeutics To Advance Pompe Disease Treatment MZE001

In May 2023, Sanofi, a France-based pharmaceutical company, partnered with Maze Therapeutics to advance its glycogen synthase 1 (GYS1) program and lead candidate MZE001 for Pompe disease. This could significantly improve patient outcomes by addressing the underlying causes of glycogen accumulation and potentially enhancing overall treatment efficacy. Maze Therapeutics is a US-based biotech company focused on developing precision medicines for rare genetic diseases.

Regional Analysis For The Global Nexviazyme Market

North America was the largest region in the nexviazyme market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nexviazyme market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nexviazyme market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Nexviazyme Market?

The nexviazyme market consists of sales of nexviazyme Infusion pumps and intravenous (IV) tubing. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nexviazyme Industry?

The nexviazyme market research report is one of a series of new reports from The Business Research Company that provides nexviazyme market statistics, including nexviazyme industry global market size, regional shares, competitors with a nexviazyme market share, detailed nexviazyme market segments, market trends and opportunities, and any further data you may need to thrive in the nexviazyme industry. This nexviazyme market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Nexviazyme Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Indication: Infantile-Onset Pompe Disease, Late-Onset Pompe Disease 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By End User: Adult, Pediatric, Geriatric
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sanofi S.A.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Nexviazyme Market Characteristics

3. Nexviazyme Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Nexviazyme Market Trends And Strategies

5. Nexviazyme Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Nexviazyme Growth Analysis And Strategic Analysis Framework

6.1. Global Nexviazyme PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Nexviazyme Market Growth Rate Analysis

6.4. Global Nexviazyme Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Nexviazyme Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Nexviazyme Total Addressable Market (TAM)

7. Global Nexviazyme Pricing Analysis & Forecasts

8. Nexviazyme Market Segmentation

8.1. Global Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Infantile-Onset Pompe Disease

Late-Onset Pompe Disease

8.2. Global Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

8.3. Global Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adult

Pediatric

Geriatric

9. Global Nexviazyme Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Nexviazyme Market Regional And Country Analysis

10.1. Global Nexviazyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Nexviazyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Nexviazyme Market

11.1. Asia-Pacific Nexviazyme Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Nexviazyme Market

12.1. China Nexviazyme Market Overview

12.2. China Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Nexviazyme Market

13.1. India Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Nexviazyme Market

14.1. Japan Nexviazyme Market Overview

14.2. Japan Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Nexviazyme Market

15.1. Australia Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Nexviazyme Market

16.1. South Korea Nexviazyme Market Overview

16.2. South Korea Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Nexviazyme Market

17.1. Western Europe Nexviazyme Market Overview

17.2. Western Europe Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Nexviazyme Market

18.1. UK Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Nexviazyme Market

19.1. Germany Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Nexviazyme Market

20.1. France Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Nexviazyme Market

21.1. Eastern Europe Nexviazyme Market Overview

21.2. Eastern Europe Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Nexviazyme Market

22.1. North America Nexviazyme Market Overview

22.2. North America Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Nexviazyme Market

23.1. USA Nexviazyme Market Overview

23.2. USA Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Nexviazyme Market

24.1. Canada Nexviazyme Market Overview

24.2. Canada Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Nexviazyme Market

25.1. South America Nexviazyme Market Overview

25.2. South America Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Nexviazyme Market

26.1. Middle East Nexviazyme Market Overview

26.2. Middle East Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Nexviazyme Market

27.1. Africa Nexviazyme Market Overview

27.2. Africa Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Nexviazyme Market Competitive Landscape And Company Profiles

28.1. Nexviazyme Market Competitive Landscape

28.2. Nexviazyme Market Company Profiles

28.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

29. Global Nexviazyme Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Nexviazyme Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Nexviazyme Market

32. Recent Developments In The Nexviazyme Market

33. Nexviazyme Market High Potential Countries, Segments and Strategies

33.1 Nexviazyme Market In 2029 - Countries Offering Most New Opportunities

33.2 Nexviazyme Market In 2029 - Segments Offering Most New Opportunities

33.3 Nexviazyme Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Nexviazyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Nexviazyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Sanofi S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Nexviazyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Nexviazyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Nexviazyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Nexviazyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Nexviazyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Sanofi S.A. Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Adm...

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

Frequently Asked Questions

What is the definition of the Nexviazyme market?

How will the Nexviazyme market drivers and restraints affect the market dynamics? What forces will shape the Nexviazyme industry going forward?

The Nexviazyme market major growth driver - Rising Prevalence Of Pompe Disease To Drive Growth In The Market. For further insights on the Nexviazyme market, request a sample here

What is the forecast market size or the forecast market value of the Nexviazyme market?

The Nexviazyme market size has grown strongly in recent years. The nexviazyme market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rising prevalence of pompe disease globally, growing investments in the rare disease treatment sector, expanding patient access to innovative therapies due to improved healthcare infrastructure, FDA approval of nexviazyme for late-onset pompe disease, and positive clinical trial results demonstrating efficacy in improving respiratory function and mobility. The nexviazyme market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing global demand for enzyme replacement therapies, growing government support for rare disease treatments, expansion of healthcare systems in emerging markets, rising research and development investments in gene therapies and related treatments, and rising healthcare spending in developed economies. Major trends in the forecast period include a shift towards more targeted and efficient enzyme therapies, growth in gene therapy research as complementary to enzyme therapies, increased use of digital health technologies for treatment monitoring, development of combination therapies for pompe disease, and advancements in biopharmaceutical manufacturing for better production efficiency. For further insights on the Nexviazyme market, request a sample here

How is the Nexviazyme market segmented?

The nexviazyme market covered in this report is segmented –
1) By Indication: Infantile-Onset Pompe Disease, Late-Onset Pompe Disease
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End User: Adult, Pediatric, Geriatric For further insights on the Nexviazyme market, request a sample here

Which region has the largest share of the Nexviazyme market? What are the other regions covered in the report?

Who are the major players in the Nexviazyme market?

Major companies operating in the nexviazyme market include Sanofi S.A. . For further insights on the Nexviazyme market, request a sample here.

What are the key trends in the Nexviazyme market?

Major trends in the Nexviazyme market include Regulatory Approval Propels Nexviazyme As A Breakthrough Therapy For Late-Onset Pompe Disease. For further insights on the Nexviazyme market, request a sample here.